Physician profile
Deepu Sudhakaran
NPI 1528269214
$29,374.90
in general payments reported to CMS, 2019-2025
27 companies · $2,479 in 2025
The $2,479 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $3,127 · 2021: $4,799 · 2022: $3,672 · 2023: $1,854 · 2024: $912 · 2025: $2,479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,436 · Education: $1,000 · Travel and Lodging: $663 · Long Term Medical Supply Or Device Loan: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,435.90 |
| Education | $1,000.00 |
| Travel and Lodging | $662.72 |
| Long Term Medical Supply Or Device Loan | $146.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $23,154.76 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Medical Device Business Services, INC. | $2,001.43 | 2021-2025 | Linx Reflux Management System |
| Ethicon US, LLC | $783.33 | 2019-2025 | Linx Reflux Management System, Echelon Flex |
| Davol INC. | $595.77 | 2023-2025 | Phasix Mesh |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $532.40 | 2025 | Relistor |
| Medtronic, INC. | $465.09 | 2022-2025 | Signia, Endoflip |
| W. L. Gore & Associates, INC. | $423.04 | 2021-2023 | Seamguard |
| Baxter Healthcare | $252.21 | 2019-2025 | Floseal, Tisseel, Peri-Strips Dry |
| Conmed Corporation | $170.99 | 2022-2024 | Airseal, Visiclear |
| Integra Lifesciences Corporation | $159.34 | 2022-2024 | Acell |
| Lilly USA, LLC | $122.95 | 2024 | Zepbound |
| Protega Pharmaceutials INC | $109.49 | 2025 | Roxybond |
| Rhythm Pharmaceuticals, INC. | $107.70 | 2023 | Imcivree |
| Endo Pharmaceuticals INC. | $90.00 | 2021-2024 | Nascobal |
| Olympus America INC. | $63.08 | 2019-2023 | Olympus |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $51.33 | 2019 | |
| Currax Pharmaceuticals LLC | $39.78 | 2022-2023 | Contrave |
| Abbott Laboratories | $38.46 | 2024 | Infinity |
| Kerecis Limited | $32.42 | 2022 | |
| Novo Nordisk INC | $30.55 | 2023 | Wegovy |
| Corcept Therapeutics | $29.03 | 2023 | Korlym |
| Kvk-Tech, INC. | $27.78 | 2025 | |
| Genmab U.S., INC. | $26.34 | 2024 | Tivdak |
| Dexcom, INC. | $18.29 | 2025 | Dexcom G6 Transmitter |
| Mimedx Group, INC. | $17.61 | 2024 | |
| Tela Bio, INC. | $16.98 | 2022 | |
| Karl Storz Endoscopy-America | $14.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepu Sudhakaran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.